<DOC>
	<DOCNO>NCT01331655</DOCNO>
	<brief_summary>The objective three-arm study evaluate effect flexible extend regimen EE+DRSP contain OC bleed pattern investigate compliance daily pill intake investigational product provide blister package compliance aid dispenser pill reminder function . The third treatment arm reference comparator arm standard 24+4 regimen identical hormone combination .</brief_summary>
	<brief_title>Clinical Study Conventional Flexible Extended Oral Contraceptive EE/DRSP With Without Metafolin Latin America</brief_title>
	<detailed_description />
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Healthy female volunteer 18 35 year age ( smoker 30 year , inclusive ) request contraceptive protection Pregnancy lactation ( le 3 month since delivery , abortion , lactation start treatment ) Body mass index ( BMI ) &gt; /= 30.0 kg/m2 Presence history venous arterial thrombotic/thromboembolic event Repeated measurement systolic blood pressure &gt; 140 mmHg and/or diastolic blood pressure &gt; 90 mmHg Presence history liver tumor ( benign malignant ) , severe hepatic disease , jaundice and/or pruritus related cholestasis , cholestatic jaundice associate pregnancy previous combine oral contraceptive ( COC ) use Uncontrolled diabetes mellitus and/or diabetes mellitus vascular involvement Severe dyslipoproteinemia Malignant premalignant disease Uncontrolled thyroid disorder Chronic inflammatory bowel disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>